MRM
MEDIROM Healthcare Technologies Inc.
Personal Products & Services
Market Cap$6M
5Y Perf.-91.9%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
MRM vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
AMZN
Amazon.com, Inc.
Specialty Retail
Market Cap$2.92T
5Y Perf.+66.5%
MRM vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | MRM | AMZN |
|---|---|---|
| Industry | Personal Products & Services | Specialty Retail |
| Market Cap | $6M | $2.92T |
| Revenue (TTM) | $11.91B | $742.78B |
| Net Income (TTM) | $615M | $90.80B |
| Gross Margin | 26.4% | 50.6% |
| Operating Margin | -0.9% | 11.5% |
| Forward P/E | 6.4x | 34.8x |
| Total Debt | $3.96B | $152.99B |
| Cash & Equiv. | $329M | $86.81B |
MRM vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
MRM
AMZN
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| MEDIROM Healthcare … (MRM) | 100 | 8.1 | -91.9% |
| Amazon.com, Inc. (AMZN) | 100 | 166.5 | +66.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRM vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MRM leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Amazon.com, Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
MRM
MEDIROM Healthcare Technologies Inc.
The Growth Play
MRM carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 21.5%, EPS growth 28.1%, 3Y rev CAGR 15.3%
- PEG 0.13 vs AMZN's 1.24
- 21.5% revenue growth vs AMZN's 12.4%
Best for: growth exposure and valuation efficiency
AMZN
Amazon.com, Inc.
The Long-Run Compounder
AMZN is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 7.0% 10Y total return vs MRM's -92.3%
- Lower volatility, beta 1.51, Low D/E 37.2%, current ratio 1.05x
- Beta 1.51, current ratio 1.05x
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MRM | 21.5% revenue growth vs AMZN's 12.4% |
| Value | MRM | Lower P/E (6.4x vs 34.8x), PEG 0.13 vs 1.24 |
| Quality / Margins | AMZN | 12.2% margin vs MRM's 5.2% |
| Stability / Safety | AMZN | Lower D/E ratio (37.2% vs 333.1%) |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | MRM | +47.9% vs AMZN's +43.7% |
| Efficiency (ROA) | MRM | 11.8% ROA vs AMZN's 11.5%, ROIC -0.3% vs 14.7% |
MRM vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
MRM vs AMZN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLAMZNLAGGINGMRM
MRMMEDIROM Healthcare Te…
1leads
AMZNAmazon.com, Inc.
2leads
6 Total Categories
CATEGORYLEADERvs MRMMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
AMZN5/6
Valuation MetricsMultiples, price ratios, and targets
MRM5/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
AMZN5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
AMZN leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 62.4x MRM's $11.9B. AMZN is the more profitable business, keeping 12.2% of every revenue dollar as net income compared to MRM's 5.2%. On growth, AMZN holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | MRMMEDIROM Healthcar… | AMZNAmazon.com, Inc. |
|---|---|---|
| RevenueTrailing 12 months | $11.9B | $742.8B |
| EBITDAEarnings before interest/tax | $338M | $155.9B |
| Net IncomeAfter-tax profit | $615M | $90.8B |
| Free Cash FlowCash after capex | -$2.0B | -$2.5B |
| Gross MarginGross profit ÷ Revenue | +26.4% | +50.6% |
| Operating MarginEBIT ÷ Revenue | -0.9% | +11.5% |
| Net MarginNet income ÷ Revenue | +5.2% | +12.2% |
| FCF MarginFCF ÷ Revenue | -16.8% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -99.4% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.5% | +74.8% |
AMZN leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
MRM leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 6.4x trailing earnings, MRM trades at a 83% valuation discount to AMZN's 37.8x P/E. Adjusting for growth (PEG ratio), MRM offers better value at 0.13x vs AMZN's 1.35x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | MRMMEDIROM Healthcar… | AMZNAmazon.com, Inc. |
|---|---|---|
| Market CapShares × price | $6M | $2.92T |
| Enterprise ValueMkt cap + debt − cash | $29M | $2.98T |
| Trailing P/EPrice ÷ TTM EPS | 6.36x | 37.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 34.77x |
| PEG RatioP/E ÷ EPS growth rate | 0.13x | 1.35x |
| EV / EBITDAEnterprise value multiple | 16.75x | 20.47x |
| Price / SalesMarket cap ÷ Revenue | 0.11x | 4.07x |
| Price / BookPrice ÷ Book value/share | 0.89x | 7.14x |
| Price / FCFMarket cap ÷ FCF | — | 378.98x |
MRM leads this category, winning 5 of 5 comparable metrics.
Profitability & Efficiency
Evenly matched — MRM and AMZN each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
MRM delivers a 2.4% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $23 for AMZN. AMZN carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to MRM's 3.33x.
| Metric | MRMMEDIROM Healthcar… | AMZNAmazon.com, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +2.4% | +23.3% |
| ROA (TTM)Return on assets | +11.8% | +11.5% |
| ROICReturn on invested capital | -0.3% | +14.7% |
| ROCEReturn on capital employed | -0.5% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 |
| Debt / EquityFinancial leverage | 3.33x | 0.37x |
| Net DebtTotal debt minus cash | $3.6B | $66.2B |
| Cash & Equiv.Liquid assets | $329M | $86.8B |
| Total DebtShort + long-term debt | $4.0B | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.56x | 39.96x |
Evenly matched — MRM and AMZN each lead in 4 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMZN five years ago would be worth $16,476 today (with dividends reinvested), compared to $1,176 for MRM. Over the past 12 months, MRM leads with a +47.9% total return vs AMZN's +43.7%. The 3-year compound annual growth rate (CAGR) favors AMZN at 36.8% vs MRM's -41.5% — a key indicator of consistent wealth creation.
| Metric | MRMMEDIROM Healthcar… | AMZNAmazon.com, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -40.8% | +19.7% |
| 1-Year ReturnPast 12 months | +47.9% | +43.7% |
| 3-Year ReturnCumulative with dividends | -80.0% | +156.2% |
| 5-Year ReturnCumulative with dividends | -88.2% | +64.8% |
| 10-Year ReturnCumulative with dividends | -92.3% | +697.8% |
| CAGR (3Y)Annualised 3-year return | -41.5% | +36.8% |
AMZN leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — MRM and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
MRM is the less volatile stock with a -0.54 beta — it tends to amplify market swings less than AMZN's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.3% from its 52-week high vs MRM's 26.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | MRMMEDIROM Healthcar… | AMZNAmazon.com, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.54x | 1.51x |
| 52-Week HighHighest price in past year | $4.45 | $278.56 |
| 52-Week LowLowest price in past year | $0.72 | $185.01 |
| % of 52W HighCurrent price vs 52-week peak | +26.1% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 81.1 |
| Avg Volume (50D)Average daily shares traded | 378K | 45.5M |
Evenly matched — MRM and AMZN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | MRMMEDIROM Healthcar… | AMZNAmazon.com, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $306.77 |
| # AnalystsCovering analysts | — | 94 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
AMZN leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MRM leads in 1 (Valuation Metrics). 2 tied.
Best OverallAmazon.com, Inc. (AMZN)Leads 2 of 6 categories
Loading custom metrics...
MRM vs AMZN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is MRM or AMZN a better buy right now?
For growth investors, MEDIROM Healthcare Technologies Inc.
(MRM) is the stronger pick with 21. 5% revenue growth year-over-year, versus 12. 4% for Amazon. com, Inc. (AMZN). MEDIROM Healthcare Technologies Inc. (MRM) offers the better valuation at 6. 4x trailing P/E, making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRM or AMZN?
On trailing P/E, MEDIROM Healthcare Technologies Inc.
(MRM) is the cheapest at 6. 4x versus Amazon. com, Inc. at 37. 8x.
03Which is the better long-term investment — MRM or AMZN?
Over the past 5 years, Amazon.
com, Inc. (AMZN) delivered a total return of +64. 8%, compared to -88. 2% for MEDIROM Healthcare Technologies Inc. (MRM). Over 10 years, the gap is even starker: AMZN returned +697. 8% versus MRM's -92. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRM or AMZN?
By beta (market sensitivity over 5 years), MEDIROM Healthcare Technologies Inc.
(MRM) is the lower-risk stock at -0. 54β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately -378% more volatile than MRM relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 3% for MEDIROM Healthcare Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MRM or AMZN?
By revenue growth (latest reported year), MEDIROM Healthcare Technologies Inc.
(MRM) is pulling ahead at 21. 5% versus 12. 4% for Amazon. com, Inc. (AMZN). On earnings-per-share growth, the picture is similar: Amazon. com, Inc. grew EPS 29. 7% year-over-year, compared to 28. 1% for MEDIROM Healthcare Technologies Inc.. Over a 3-year CAGR, MRM leads at 15. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRM or AMZN?
Amazon.
com, Inc. (AMZN) is the more profitable company, earning 10. 8% net margin versus 1. 8% for MEDIROM Healthcare Technologies Inc. — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMZN leads at 11. 2% versus -0. 2% for MRM. At the gross margin level — before operating expenses — AMZN leads at 50. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — MRM or AMZN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is MRM or AMZN better for a retirement portfolio?
For long-horizon retirement investors, MEDIROM Healthcare Technologies Inc.
(MRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 54)). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MRM: -92. 3%, AMZN: +697. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MRM and AMZN?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MRM is a small-cap high-growth stock; AMZN is a mega-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(MRM: -99.4% · AMZN: 16.6%)Net Margin>
%
(MRM: 5.2% · AMZN: 12.2%)P/E Ratio<
x
(MRM: 6.4x · AMZN: 37.8x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.